Select Bibliography

Filter by any of these (after searching):

Wang, Xiaofei

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 62 items

Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503)

Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - AATS - - 2018

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-140503

Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503)

Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - - Lancet Respir Med - 2018

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0010

Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance)

Augert, Arnaud , Zhang, Qing , Bates, Breanna , Cui, Min ... - - J Thorac Oncol - 2017

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-151111

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

Baggstrom, Maria Q. , Socinski, Mark A. , Wang, Xiaofei F. , Gu, Lin ... - - J Thorac Oncol - 2017

Manuscript - Primary - Primary - Respiratory - CALGB-30607 , CALGB-70701

Phase I Study of Accelerated Conformal Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Patients With Pulmonary Dysfunction: CALGB 39904

Bogart, Jeffrey A. , Hodgson, Lydia , Seagren, Stephen L. ... - - J Clin Oncol - 2010

Manuscript - Primary - Primary - Respiratory - CALGB-39904

Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538

Bogart, Jeffrey , Wang, Xiaofei , Masters, Gregory , Gao, Junheng ... - - Lung Cancer - 2021

Manuscript - Secondary - Primary - Respiratory - CALGB-30610

Phase III Comparison of High Dose Once-Daily (QD) Thoracic Radiotherapy (TRT) with Standard Twice-Daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance) / RTOG 0538

Bogart, Jeffrey , Wang, Xiaofei , Masters, Gregory , Gao, Junheng ... - ASCO - J Clin Oncol - 2021

Abstract - Primary - Primary - Respiratory - CALGB-30610

Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on the experimental thoracic radiotherapy (TRT) arms of CALGB 30610 (Alliance) / RTOG 0538

Bogart, Jeffrey , Wang, Xiaofei , Masters, Gregory , Zhu, Han ... - ESMO - Ann Oncol - 2019

Abstract - Secondary - Primary - Respiratory - CALGB-30610

Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non-small cell lung cancer; Results from CALGB 159902

Boylan, Alice M. , Wang, Xiaofei F , Ko, Richard , Watson, Patricia M ... - - J. Thorac. Cardiovasc. Surg. - 2013

Manuscript - Secondary - Primary - Respiratory - CALGB-159902

Multi-institutional prospective validation of prognostic mRNA signatures in early stage squamous lung cancer (Alliance)

Bueno, Raphael , Richards, William G. , Harpole, David H. ... - - J Thorac Oncol - 2020

Manuscript - Primary - Meta-Analysis - Correl Sci NOS - CALGB-150807 , CALGB-140202

Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)

Demmy, Todd L. , Gu, Lin , Burkhalter, Jack E. , Toloza, Eric M. ... - - J Natl Compr Canc Netw - 2012

Manuscript - Primary - Primary - Respiratory - CALGB-30102

A phase II study of sorafenib in malignant mesothelioma: results of CALGB 30307

Dubey, Sarita , Jänne, Pasi A. , Krug, Lee , Pang, Herbert ... - - J Thorac Oncol - 2010

Manuscript - Primary - Primary - Respiratory - CALGB-30307

Randomized Study of Maintenance Pemetrexed versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901

Dudek, Arkadiusz Z. , Wang, Xiaofei , Gu, Lin , Duong, Stephanie ... - - Clin Lung Cancer - 2020

Manuscript - Primary - Primary - Respiratory - CALGB-30901

Randomized phase 2 study of maintenance pemetrexed versus observation for patients (pts) with malignant pleural mesothelioma (MPM) without progression after first-line chemotherapy: Cancer and Leukemia Group B (CALGB/Alliance) 30901

Dudek, Arkadiusz Z. , Wang, Xiaofei , Gu, Lin , Stinchcombe, Thomas ... - ASCO - J Clin Oncol - 2019

Abstract - Primary - Primary - Respiratory - CALGB-30901

CYFRA 21-1 as a prognostic and predictive marker in advanced non-small cell lung cancer in a prospective trial: CALGB 150304

Edelman, Martin J. , Hodgson, Lydia , Rosenblatt, Paula Y. ... - - J Thorac Oncol - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150304

Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304

Edelman, Martin J. , Hodgson, Lydia , Wang, Xiaofei ... - - J Thorac Oncol - 2011

Manuscript - Secondary - Primary - Respiratory - CALGB-150304 , CALGB-30203

Final Results of a phase III trial of celecoxib (C) in addition to standard chemotherapy for advanced NSCLC with COX- 2 overexpression: CALGB 30801 (Alliance)

Edelman, Martin J. , Wang, Xiaofei , Hodgson, Lydia ... - MSTO - Int. J. Radiat. Oncol. Biol. Phys. - 2017

Abstract - Primary - Primary - Respiratory - CALGB-30801

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)

Edelman, Martin J. , Wang, Xiaofei , Hodgson, Lydia ... - - J. Clin. Oncol - 2017

Manuscript - Primary - Primary - Respiratory - CALGB-30801

Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.

Edelman, Martin J , Watson, Dee , Wang, Xiaofei , Morrison, Carl ... - - J. Clin. Oncol. - 2008

Manuscript - Primary - Primary - Respiratory - CALGB-30203

Multi-Trial Evaluation of Progression-Free Survival (PFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Foster, Nathan R. , Renfro, Lindsay A. , Schild, Steven E. ... - - J Thorac Oncol - 2015

Manuscript - Secondary-not-in-original - Meta-Analysis - Respiratory - CALGB-30103 , N0424 , NCCTG-932053

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407

Govindan, Ramaswamy , Bogart, Jeffrey , Stinchcombe, Thomas ... - - J Clin Oncol - 2011

Manuscript - Primary - Primary - Respiratory - CALGB-30407

A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.

Govindan, Ramaswamy , Wang, Xiaofei , Baggstrom, Maria Q ... - - J Thorac Oncol - 2009

Manuscript - Primary - Primary - Respiratory - CALGB-30104

Prognostic Significance of Mucin and p53 Expression in Stage IB Non-Small Cell Lung Cancer: A Laboratory Companion Study to CALGB 9633

Graziano, Stephen L. , Gu, Lin , Wang, Xiaofei , Tatum, Arthur H. ... - - J Thorac Oncol - 2010

Manuscript - Secondary - Primary - Respiratory - CALGB-9633

Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901.

Graziano, Stephen L , Herndon, James E , Socinski, Mark A ... - - J Thorac Oncol - 2008

Manuscript - Primary - Primary - Respiratory - CALGB-39901

A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Heist, Rebecca S. , Wang, Xiaofei , Hodgson, Lydia ... - - J Thorac Oncol - 2014

Manuscript - Primary - Primary - Respiratory - CALGB-30704

Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC

Hensing, Thomas A. , Wang, Xiaofei , Stinchcombe, Thomas E. ... - - JTO Clin Res Rep - 2021

Manuscript - Primary - Primary - Respiratory - AFT-09

Randomized multicenter phase II trial evaluating the sequencing of PD-1 inhibition with pembrolizumab (ppembro) and standard platinum-based chemotherapy (chemo) in patients (pts) with metastatic non-small cell lung cancer (NSCLC) AFT-09 (Alliance)

Hensing, Thomas , Wang, Xiaofei , Kozono, David , Dudek, Arkadius ... - ASCO - J. Clin. Oncol. - 2019

Abstract - Primary - Primary - Respiratory - AFT-09

Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).

Jahan, Thierry , Gu, Lin , Kratzke, Robert , Dudek, Arkadiusz ... - - Lung Cancer - 2012

Manuscript - Primary - Primary - Respiratory - CALGB-30107

Biopsy first: Lessons learned from CALGB 140503

Kohman, Leslie J. , Gu, Lin , Altorki, Nasser , Scalzetti, Ernest ... - - J. Thorac. Cardiovasc. Surg. - 2017

Manuscript - Secondary-not-in-original - Primary - Respiratory - A081202 , CALGB-140503 , CALGB-580602

Surgeon Error In Predicting Stage I Non-Small Cell Lung Cancer (NSCLC) Is A Major Factor Precluding Randomization In CALGB 140503 (Alliance)

Kohman, Leslie J. , Gu, Lin , Altorki, Nasser , Veit, Linda J. ... - AATS - - 2016

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-140503

Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.

Kratzke, Robert A , Wang, Xiaofei , Wong, Long , Kratzke, Marian G ... - - J Thorac Oncol - 2008

Manuscript - Secondary - Primary - Respiratory - CALGB-159904

Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients

Le‐Rademacher, Jennifer , Lopez, Camden , Wolfe, Eric ... - - J Cachexia Sarcopenia Muscle - 2020

Manuscript - Secondary-not-in-original - Primary - Health Outcome - A151822

A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor risk stage III non-small cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

Lilenbaum, Rogerio , Samuels, Michael , Wang, Xiaofei ... - - J Thorac Oncol - 2015

Manuscript - Primary - Primary - Respiratory - CALGB-30605

Randomized Phase II Trial of Docetaxel Plus Cetuximab or Docetaxel Plus Bortezomib in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2: CALGB 30402

Lilenbaum, Rogerio , Wang, Xiaofei , Gu, Lin , Kirshner, Jeffrey ... - - J Clin Oncol - 2009

Manuscript - Primary - Primary - Respiratory - CALGB-30402

Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial.

Liptay, Michael J , D'amico, Thomas A , Nwogu, Chumy , Demmy, Todd L ... - - J Thorac Oncol - 2009

Manuscript - Primary - Primary - Respiratory - CALGB-140203

Detection of Occult Micrometastases in Patients With Clinical Stage I Non–Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance)

Martin, Linda W. , D'Cunha, Jonathan , Wang, Xiaofei , Herzan, Debra ... - - J. Clin. Oncol - 2016

Manuscript - Primary - Long-Term-Followup - Respiratory - C9761

CHIO3: Chemotherapy combined with immune checkpoint inhibitor for operable stage IIIA/B non-small cell lung cancer (AFT-46)

Martin, Linda W. , Wang, Xiaofei , Patel, Jyoti D. , Kozono, David ... - IASLC (WCLC) - J Thorac Oncol - 2021

Abstract - No-Endpoint - Trial-Description-Only - Respiratory - AFT-46

A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531

Masters, Gregory A. , Wang, Xiaofei , Hodgson, Lydia , Shea, Thomas ... - - Lung Cancer - 2011

Manuscript - Primary - Primary - Respiratory - CALGB-9531

Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.

Miller, Antonius A , Wang, Xiaofei F , Bogart, Jeffrey A ... - - J Thorac Oncol - 2007

Manuscript - Primary - Primary - Respiratory - CALGB-30002

Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).

Miller, Antonius A , Wang, Xiaofei F , Gu, Lin , Hoffman, Philip ... - - J Thorac Oncol - 2008

Manuscript - Primary - Primary - Respiratory - CALGB-30303

VATS Lobectomy Has Better Peri-operative Outcomes than open Lobectomy: CALGB 31001, an Ancillary Analysis of CALGB 140202 (Alliance)

Nwogu, Chukwumere E. , D'Cunha, Jonathan , Pang, Herbert , Gu, Lin ... - - Ann. Thorac. Surg. - 2015

Manuscript - Secondary - Primary - Respiratory - CALGB-31001 , CALGB-140202

Validation of the CALGB and EORTC Prognostic Models for Mesothelioma Based on Multiple CALGB Trials (Alliance)

Pang, Herbert , Hodgson, Lydia , Kratzke, Robert , Crawford, Jeffrey ... - IASLC (WCLC) - J Thoracic Oncol - 2013

Abstract - Secondary-not-in-original - Meta-Analysis - Respiratory - CALGB-8435 , CALGB-8638 , CALGB-8833 , CALGB-8933 , CALGB-9031 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733 , CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807

Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance)

Pang, Herbert , Yan, Kang , Kratzke, Robert , Stinchcombe, Thomas ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint - Meta-Analysis - Respiratory - CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-8435 , CALGB-8638 , CALGB-8833 , CALGB-8933 , CALGB-9031 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733

Adherence and Persistence With Oral Adjuvant Chemotherapy in Older Women With Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104

Partridge, Ann H. , Archer, Laura , Kornblith, Alice B. ... - - J Clin Oncol - 2010

Manuscript - Primary - Primary - Experimental - CALGB-60104 , CALGB-49907

A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734.

Perry, Michael C , Kohman, Leslie J , Bonner, James A , Gu, Lin ... - - Clin Lung Cancer - 2007

Manuscript - Primary - Primary - Respiratory - C9734

Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: Cancer and Leukemia group B (CALGB) 30106, a CALGB-stratified phase II trial.

Ready, Neal , Jänne, Pasi A , Bogart, Jeffrey , Dipetrillo, Thomas ... - - J Thorac Oncol - 2010

Manuscript - Primary - Primary - Respiratory - CALGB-30106 , CALGB-150508

Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC

Ross, Helen J. , Kozono, David , Urbanic, James , Williams, Terence ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint - Trial-Description-Only - Respiratory - AFT-16

AFT-16: Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Unresectable Stage III NSCLC

Ross, Helen J. , Kozono, David , Urbanic, James , Williams, Terence ... - ASCO - J Clin Oncol - 2020

Abstract - Primary - Preliminary - Respiratory - AFT-16

AFT-16: Phase II Trial of Neoadjuvant and adjuvant Atezolizumab (A) and Chemoradiation (CRT) for Stage III Non-small Cell Lung Cancer (NSCLC)

Ross, Helen J. , Kozono, David , Urbanic, James , Williams, Terence ... - ASCO - J Clin Oncol - 2021

Abstract - Primary - Primary - Respiratory - AFT-16

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

Rudin, Charles M. , Salgia, Ravi , Wang, Xiaofei , Hodgson, Lydia D. ... - - J. Clin. Oncol. - 2008

Manuscript - Primary - Primary - Respiratory - CALGB-30103

Positive Interaction Between Prophylactic Cranial Irradiation And Maintenance Sunitinib For Untreated Extensive Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis Of CALGB 30504 (Alliance)

Salama, Joseph K. , Gu, Lin , Wang, Xiaofei , Pang, Herbert H. ... - - J Thorac Oncol - 2016

Manuscript - Secondary-not-in-original - Primary - Respiratory - CALGB-30504

Pulmonary toxicity in stage III non-small cell lung cancer patients treated with high dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: A secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105

Salama, Joseph K. , Stinchcombe, Thomas E. , Gu, Lin , Wang, Xiaofei ... - - Int J Radiat Oncol Biol Phys - 2011

Manuscript - Secondary - Primary - Respiratory - CALGB-30105

PCI Survival Improvement for Extensive Stage SCLC Limited to Patients on Maintenance Systemic Therapy: A Secondary Analysis of CALGB 30504 (Alliance)

Salama, Josept K. , Gu, Lin , Wang, Xiaofei , Bogart, Jeffrey ... - IASLC (WCLC) - J Thorac Oncol - 2015

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-30504

Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial.

Socinski, Mark A. , Wang, Xiaofei F. , Baggstrom, Maria Quintos ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Respiratory - CALGB-30607

Switch Maintenance with Sunitinib (S) in Advanced Non-Small Cell Lung Cancer (NSCLC): An Alliance (CALGB 30607), Randomized, Placebo-controlled Phase III Trial

Socinski, Mark A. , Wang, Xiaofei F. , Baggstrom, Maria Quintos ... - MSTO - Int. J. Radiat. Oncol. Biol. Phys. - 2014

Abstract - Primary - Primary - Respiratory - CALGB-30607

Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.

Socinski, Mark A , Blackstock, A William , Bogart, Jeffrey A ... - - J. Clin. Oncol. - 2008

Manuscript - Primary - Primary - Respiratory - CALGB-30105

Phase I Study of Accelerated Hypofractionated Radiotherapy with Concurrent Chemotherapy for Stage III Non-Small-Cell Lung Cancer: CALGB 31102 (Alliance)

Urbanic, James J. , Wang, Xiaofei , Bogart, Jeffrey A. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2018

Manuscript - Primary - Primary - Respiratory - CALGB-31102

Phase I Study of Accelerated Hypofractionated Radiotherapy with Concurrent Chemotherapy for Stage III Non-Small-Cell Lung Cancer: CALGB 31102 (Alliance)

Urbanic, James J , Bogart, Jeffrey A , Stinchcombe, Thomas ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2015

Abstract - Primary - Primary - Respiratory - CALGB-31102

Validation of Survival Prognostic Models for Non-Small-Cell Lung Cancer in Stage- and Age-specific Groups

Wang, Xiaofei , Gu, Lin , Zhang, Ying , Sargent, Daniel J. ... - - Lung Cancer - 2015

Manuscript - Secondary-not-in-original - Meta-Analysis - Respiratory - C8834 , C8836 , C8931 , C8932 , C9132 , C9532 , CALGB-140202 , CALGB-140203 , CALGB-30203 , CALGB-30303 , CALGB-30402 , CALGB-30406 , CALGB-30506 , CALGB-30704 , CALGB-39802 , CALGB-39809 , CALGB-39904 , CALGB-9238 , CALGB-9335 , CALGB-9633 , CALGB-9730 , CALGB-9731 , CALGB-9761 , Comprehensive

Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials

Wang, Xiaofei , Wang, Xiaoyi , Hodgson, Lydia , George, Stephen L. ... - - Oncologist - 2017

Manuscript - Secondary-not-in-original - Primary - Respiratory - C8435 , C8638 , C8833 , C8933 , C9031 , CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733 , N0021 , NCCTG-N0623

Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non‐Small Cell Lung Cancer in CALGB 9730 (Alliance A151729)

Wong, Melisa L. , Gao, Junheng , Thanarajasingam, Gita ... - - Oncologist - 2021

Manuscript - Primary - Primary - Older Adult - A151729 , CALGB-9730

Comparison of chemotherapy toxicity over time according to age and performance status in patients with advanced non-small cell lung cancer: a toxicity over time analysis of CALGB 9730 (Alliance A151729)

Wong, Melisa L. , Gao, Junheng , Thanarajasingam, Gita ... - SIOG (ISOG) - J Geriatric Oncol - 2018

Abstract - Primary - Primary - Older Adult - CALGB-9730